tiprankstipranks
TipRanksTop Financial ExpertsInsidersJason Rhodes

Jason Rhodes Insider Profile

4 Followers
Jason Rhodes, Director at Dyne Therapeutics, holds 431.91K shares in Dyne Therapeutics (Ticker: DYN), holds ― shares in Disc Medicine (Ticker: IRON), holds 0.00 shares in Generation Bio (Ticker: GBIO).
See the Hottest Stocks Based on Insider Trading >
tipranks
Jason Rhodes

Jason Rhodes
Dyne Therapeutics (DYN)
Director

Ranked #7,901 out of 109,030 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

+57.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$50M
84.14%
15.86%
0.00%
A breakdown of Jason Rhodes's holdings
See the Top Stocks by Insiders

Insider Roles

Replimune Group
(REPL)
Director
Dyne Therapeutics
(DYN)
Director
Disc Medicine
(IRON)
Director, Ten Percent Owner
Roles that Jason Rhodes holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Replimune Group
(REPL)
Rating:Informative Buy
Date:Nov 20, 2019 - Nov 20, 2020
Return:+276.70%
The most profitable trade made by Jason Rhodes
See the Latest Stocks Traded by Insiders

Jason Rhodes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DYN
Dyne Therapeutics
Aug 17, 2026
Director
Uninformative Sell
65.18M
$7.87M
IRON
Disc Medicine
―
Director, Ten Percent Owner
―
―
EPZM
Epizyme
Sep 24, 2014
―
Informative Buy
22.44K
$202.86K
REPL
Replimune Group
Jan 28, 2021
Director
Uninformative Sell
256.45K
$41.72M
GBIO
Generation Bio
Feb 09, 2026
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Jason Rhodes's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jason Rhodes insider profile FAQ

What is the percentage of profitable transactions made by Jason Rhodes?
The percentage of profitable transactions made by Jason Rhodes is 60%.
    What is the average return per transaction made by Jason Rhodes?
    The average return per transaction made by Jason Rhodes is 57.60%.
      What stocks does Jason Rhodes hold?
      Jason Rhodes holds: DYN, IRON, EPZM, REPL, GBIO stocks.
        What was Jason Rhodes’s latest transaction?
        Jason Rhodes latest transaction was an Uninformative Sell of $65.18M.
          What was Jason Rhodes's most profitable transaction?
          Jason Rhodes’s most profitable transaction was an Informative Buy of REPL stock on November 20, 2019. The return on the trade was 276.70%.
            What is Jason Rhodes's role in Dyne Therapeutics?
            Jason Rhodes's role in Dyne Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.